New study to measure hidden toll of rare skin diseases on patients and families
NCT ID NCT05954416
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand the full burden of 9 rare skin diseases—including physical, emotional, social, and financial challenges—on patients and their families. Researchers will use special questionnaires to track how these conditions affect daily life and care needs. About 900 adults and children with confirmed diagnoses will participate, helping to improve future support and resources.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBINISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Avicenne
NOT_YET_RECRUITINGBobigny, France
-
Hôpital Charles Nicolle
RECRUITINGRouen, France
-
Hôpital Dupuytren
NOT_YET_RECRUITINGLimoges, France
-
Hôpital François Mitterrand
NOT_YET_RECRUITINGDijon, France
-
Hôpital Henri-Mondor
NOT_YET_RECRUITINGCréteil, France
-
Hôpital Larrey
RECRUITINGToulouse, France
-
Hôpital Necker-Enfants Malades
RECRUITINGParis, France
-
Hôpital Robert-Debré
NOT_YET_RECRUITINGReims, France
-
Hôpital Saint-Eloi
NOT_YET_RECRUITINGMontpellier, France
-
Hôpital Saint-Louis
RECRUITINGParis, France
-
Hôpital Trousseau
RECRUITINGTours, France
-
Hôpital de la Timone
NOT_YET_RECRUITINGMarseille, France
-
Hôpital des Enfants - Groupe Hospitalier Pellegrin
NOT_YET_RECRUITINGBordeaux, France
-
Hôpital des Enfants - Groupe Hospitalier Pellegrin
NOT_YET_RECRUITINGBordeaux, France
-
Hôpital l'Archet
RECRUITINGNice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-World study tracks Selumetinib's impact on NF1 tumors in children
- Could a cholesterol drug boost reading skills in kids with NF1?
- Antioxidant drug shows promise for kids with NF1
- Scientists probe hidden clot risks in autoimmune skin disorders
- Experimental CAR-T injection aims to tame autoimmune diseases
- Massive eye gene bank aims to unlock secrets of rare blindness